Bonesupport Holding AB (publ) (BOEUF)
USD 32.55
(-2.11%)
USD 32.55
(-2.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 526.98 Million SEK | 39.86% |
| 2022 | 365.31 Million SEK | 33.19% |
| 2021 | 274.27 Million SEK | 6.39% |
| 2020 | 257.79 Million SEK | -12.19% |
| 2019 | 293.59 Million SEK | 14.25% |
| 2018 | 256.98 Million SEK | 22.42% |
| 2017 | 209.91 Million SEK | 17.88% |
| 2016 | 178.07 Million SEK | 67.11% |
| 2015 | 106.56 Million SEK | 37.23% |
| 2014 | 77.65 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 145.26 Million SEK | -6.21% |
| 2024 Q3 | 179.66 Million SEK | 3.81% |
| 2024 Q2 | 173.08 Million SEK | 19.15% |
| 2023 Q4 | 154.88 Million SEK | 18.31% |
| 2023 Q2 | 122.25 Million SEK | 13.65% |
| 2023 Q1 | 107.56 Million SEK | -7.87% |
| 2023 Q3 | 130.91 Million SEK | 7.09% |
| 2023 FY | 510.93 Million SEK | 39.86% |
| 2022 FY | 365.31 Million SEK | 33.19% |
| 2022 Q1 | 76.49 Million SEK | -4.97% |
| 2022 Q2 | 81.29 Million SEK | 6.27% |
| 2022 Q4 | 116.76 Million SEK | 28.64% |
| 2022 Q3 | 90.76 Million SEK | 11.66% |
| 2021 Q1 | 59.4 Million SEK | -17.54% |
| 2021 Q4 | 80.49 Million SEK | 29.61% |
| 2021 Q3 | 62.1 Million SEK | -14.06% |
| 2021 Q2 | 72.26 Million SEK | 21.66% |
| 2021 FY | 274.27 Million SEK | 6.39% |
| 2020 Q3 | 63.17 Million SEK | 15.22% |
| 2020 Q4 | 72.04 Million SEK | 14.03% |
| 2020 Q1 | 67.73 Million SEK | -14.58% |
| 2020 Q2 | 54.83 Million SEK | -19.05% |
| 2020 FY | 257.79 Million SEK | -12.19% |
| 2019 Q2 | 80.09 Million SEK | 19.2% |
| 2019 Q4 | 79.3 Million SEK | 18.35% |
| 2019 Q1 | 67.19 Million SEK | 2.11% |
| 2019 FY | 293.59 Million SEK | 14.25% |
| 2019 Q3 | 67 Million SEK | -16.34% |
| 2018 Q3 | 70.07 Million SEK | 12.2% |
| 2018 Q1 | 58.65 Million SEK | 8.4% |
| 2018 FY | 256.98 Million SEK | 22.42% |
| 2018 Q4 | 65.8 Million SEK | -6.1% |
| 2018 Q2 | 62.45 Million SEK | 6.48% |
| 2017 Q1 | 56.26 Million SEK | 1.46% |
| 2017 FY | 209.91 Million SEK | 17.88% |
| 2017 Q4 | 54.1 Million SEK | 10.87% |
| 2017 Q3 | 48.8 Million SEK | -3.83% |
| 2017 Q2 | 50.74 Million SEK | -9.81% |
| 2016 Q4 | 55.45 Million SEK | 18.28% |
| 2016 Q2 | 42.49 Million SEK | 27.82% |
| 2016 Q1 | 33.24 Million SEK | 0.0% |
| 2016 FY | 178.07 Million SEK | 67.11% |
| 2016 Q3 | 46.88 Million SEK | 10.35% |
| 2015 FY | 106.56 Million SEK | 37.23% |
| 2014 FY | 77.65 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -18304.709% |
| Ansell Limited | 495.5 Million USD | -6.355% |
| Ansell Limited | 495.5 Million USD | -6.355% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -536.429% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -30348.371% |
| Psykey, Inc. | 1.21 Million USD | -43327.745% |
| ConvaTec Group Plc | 910.31 Million USD | 42.109% |
| ConvaTec Group Plc | 872.5 Million USD | 39.6% |
| Encision Inc. | 3.77 Million USD | -13853.471% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -371512.216% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -479279.793% |
| Innovative MedTech Inc. | 6.09 Million USD | -8540.546% |
| LifePoint, Inc. | 7.42 Million USD | -6998.548% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -8200.315% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -61535.906% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -72474.346% |
| Reflect Scientific, Inc. | 1.06 Million USD | -49442.869% |
| SmileDirectClub, Inc. | 517 Million USD | -1.931% |
| Sector 10, Inc. | 39.84 Thousand USD | -1322525.74% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 92.067% |
| SheerVision, Inc. | 2.33 Million USD | -22501.608% |
| United Health Products, Inc. | 2.42 Million USD | -21617.64% |
| Vasamed, Inc. | 4.67 Million USD | -11177.481% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -20470.934% |
| Yubo International Biotech Limited | 1.25 Million USD | -41795.021% |